Product Information
- CML
- (2S)-2-Amino-6-(carboxymethylamino)hexanoic acid
- <span class="text-smallcaps">L</span>-Lysine, N<sup>6</sup>-(carboxymethyl)-
- L-Lysine,N6-(carboxymethyl)-
- Lysine, N<sup>6</sup>-(carboxymethyl)-, <span class="text-smallcaps">L</span>-
- Lysine,N6-(carboxymethyl)-, L- (8CI)
- N-(3-chloro-4-fluorophenyl)-2-[(2-chlorophenyl)sulfanyl]acetamide
- N6-(1-Carboxymethyl)-L-lysine
- N6-(Carboxymethyl)lysine
- N<sup>6</sup>-(Carboxymethyl)-<span class="text-smallcaps">L</span>-lysine
- See more synonyms
- N<sup>6</sup>-(Carboxymethyl)lysine
- N<sup>ε</sup>-(Carboxymethyl)lysine
- Ne-(Carboxymethyl)lysine
- e-(Carboxymethyl)lysine
- N6-(Carboxymethyl)-L-lysine
- Lysine, N6-(carboxymethyl)-, L-
Nε-(1-Carboxymethyl)-L-lysine (CML), an advanced glycation end product (AGE), is formed through the oxidative modification of glycated proteins under conditions of oxidative stress.1,2,3 Its levels escalate with age, diabetes, cancer, vascular diseases, and various pathologies associated with oxidative stress.1,4,5 CML interacts with the membrane-bound receptor for AGEs (RAGE), initiating signaling via MAPKs and NF-κB pathways. Conversely, a truncated version of RAGE generates a soluble protein that sequesters CML, thereby diminishing this signaling.6,7
Chemical properties
Technical inquiry about: TM-T84435 Nε-(1-Carboxymethyl)-L-lysine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.